首页> 外文OA文献 >The GLP‐1/GIP dual‐receptor agonist DA5‐CH inhibits the NF‐κB inflammatory pathway in the MPTP mouse model of Parkinson's disease more effectively than the GLP‐1 single‐receptor agonist NLY01

【2h】

The GLP‐1/GIP dual‐receptor agonist DA5‐CH inhibits the NF‐κB inflammatory pathway in the MPTP mouse model of Parkinson's disease more effectively than the GLP‐1 single‐receptor agonist NLY01

机译：GLP-1 / GIP双受体激动剂DA5-CH抑制MPTP疾病MPTP小鼠模型中的NF-κB炎性途径，而不是GLP-1单受体激动剂NLY01

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
MiaoJun Lv; GuoFang Xue; HuiFeng Cheng; PengFei Meng; Xia Lian; Christian Hölscher; DongFang Li;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Two novel dual GLP-1/GIP receptor agonists are neuroprotective in the MPTP mouse model of Parkinson's disease [J] . Feng Peng, Zhang Xiangjian, Li Dongfang, Neuropharmacology . 2018,第期

机译：两种新的双重GLP-1 / GIP受体激动剂是帕金森病的MPTP小鼠模型中的神经保护剂
2. A novel dual GLP-1 and GIP receptor agonist is neuroprotective in the MPTP mouse model of Parkinson's disease by increasing expression of BNDF [J] . Ji Chenhui, Xue Guo-Fang, Cao Lijun, Brain research . 2016,第Null期

机译：通过增加BNDF的表达，新型的GLP-1和GIP受体双重激动剂在帕金森氏病的MPTP小鼠模型中具有神经保护作用
3. A novel dual GLP-1 and GIP incretin receptor agonist is neuroprotective in a mouse model of Parkinson's disease by reducing chronic inflammation in the brain [J] . Cao Lijun, Li Dongfang, Feng Peng, Neuroreport . 2016,第6期

机译：一种新型的双重GLP-1和GIP降钙素受体激动剂通过减轻大脑的慢性炎症在帕金森氏病的小鼠模型中具有神经保护作用
4. Solution Structure of a GLP-1 Receptor Peptidomimetic Agonist, Ac-SH3-GLP-1(22-36)-NH2 [C] . Isuru R. Kumarasinghe, Eunice Murage, Jung-Mo Ahn American Peptide Symposium . 2011

机译：GLP-1受体肽瘤激动剂的溶液结构，AC-SH3-GLP-1（22-36）-NH2
5. Selective GLP-1 receptor antagonists and glucagon/GLP-1 co-agonists discovered through an investigation into the structure-activity relationship in glucagon-related peptides. [D] . Patterson, James T. 2011

机译：通过研究胰高血糖素相关肽的结构-活性关系，发现了选择性的GLP-1受体拮抗剂和胰高血糖素/ GLP-1共激动剂。
6. Correction: Al-Zamel N. et al. A Dual GLP-1/GIP Receptor agonist Does Not Antagonize Glucagon at Its Receptor but May Act as a Biased agonist at the GLP-1 Receptor. Int. J. Mol. Sci. 2019 20 3532 [O] . Noura Al-Zamel, Suleiman Al-Sabah, Yunus Luqmani, 2020

机译：更正：Al-ZamelN.等。双重GLP-1 / GIP受体激动剂不会在其受体上拮抗胰高血糖素但可能会在GLP-1受体上充当偏向激动剂。诠释J.摩尔科学2019203532
7. A novel dual GLP-1 and GIP receptor agonist is neuroprotective in the MPTP mouse model of Parkinson′s disease by increasing expression of BNDF [O] . Ji Chenhui, Xue Guo-Fang, Lijun Cao, 2016

机译：通过增加BNDF的表达，新型的GLP-1和GIP双重受体激动剂在帕金森氏病的MPTP小鼠模型中具有神经保护作用

The GLP‐1/GIP dual‐receptor agonist DA5‐CH inhibits the NF‐κB inflammatory pathway in the MPTP mouse model of Parkinson's disease more effectively than the GLP‐1 single‐receptor agonist NLY01

著录项

引文网络

相似文献

相关主题

期刊订阅